Beginning Cash: The amount of cash reported by the company on its previous statement.
Fennec Pharmaceuticals Inc. (T.FRX) had Beginning Cash of 18.19M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
-0.60M |
|
-- |
|
-- |
|
-- |
|
3.52M |
|
-- |
|
-0.10M |
|
-0.10M |
|
-0.60M |
|
-0.60M |
|
-0.60M |
|
-0.60M |
|
3.52M |
|
4.83M |
|
27.29M |
|
27.29M |
|
-0.03 |
|
-0.03 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
61.60M |
|
-- |
|
-- |
|
-- |
|
69.65M |
|
-8.05M |
|
-8.05M |
|
-8.05M |
|
27.53M |
|
| Cash Flow Statement Financials | |
36.98M |
|
-- |
|
-18.66M |
|
|
Beginning Cash |
18.19M |
36.50M |
|
18.32M |
|
6.94M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.38 |
|
-- |
|
-- |
|
1.48 |
|
-3.08 |
|
93.30% |
|
5.40% |
|
5.40% |
|
7.42% |
|
-0.15% |
|
-0.92% |
|
36.98M |
|
-- |
|
-- |
|
-- |
|
1.06 |
|
3.00 |
|
3.69 |
|
98.92 |
|
7.43% |
|
7.43% |
|
-0.97% |
|
-3.58% |
|
-0.29 |
|
1.35 |
|
1.35 |
|